Freedom Capital initiated coverage of Globus Medical (GMED) with a Hold rating and $87 price target The firm says the company’s “solid” organic growth is already reflected in the shares.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on GMED: